ArticleAnnals of hematology2023

Efficacy and Safety of Ixazomib Plus Lenalidomide and Dexamethasone Following Injectable PI-Based Therapy in Relapsed/Refractory Multiple Myeloma.

Yu Abe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.